Navigation Links
Positive Clinical Study Results for BSP's HyperQ Technology
Date:11/14/2011

TEL-AVIV, Israel, November 14, 2011 /PRNewswire/ --

BSP Biological Signal Processing Ltd. (BSP) (TASE: BSP), which develops and manufactures products for the non-invasive, accurate diagnosis of Coronary Artery Disease (CAD), recently announced the successful completion of a comprehensive clinical research study evaluating the performance of the company's HyperQ technology in diagnosing CAD. An article describing the study and its results was accepted for publication in the prestigious American Journal of Cardiology.

The study recruited 996 patients and compared the clinical performance of HyperQ vs. conventional ECG for the detection of Coronary Artery Disease (CAD), using nuclear imaging as the gold standard. The study was conducted in two major medical centers in Israel - Assuta Medical Center and Sheba Medical Center, and was headed by Dr. Tali Sharir and Prof. Pierre Chouraqui.  The major finding reported by the researchers is a 30% improvement in the sensitivity of the HyperQ analysis in the detection of CAD when compared to conventional stress ECG. HyperQ analysis also had a lower false alarm rate compared to conventional stress ECG.


"This comprehensive study significantly deepens clinical knowledge accumulated so far by our company and substantiates the evidence that HyperQ improves the ability to diagnose ischemic heart disease," says Nissim Greisas, CEO of BSP.  He added, "We believe that the results of this study will have a major impact on the decision of cardiologists to clinically implement the use of HyperQ products in their routine workup for diagnosing and assessing ischemic heart disease."

The results of this study were also recently presented, together with additional HyperQ related clinical evidence, at a meeting and hearing of the Medicare Evidence Development & Coverage Advisory Committee (MEDCAC) in the US. The MEDCAC m
'/>"/>

SOURCE BSP - Biological Signal Processing Ltd
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. ChemoCentryx Presents Positive Results for Novel CCR2 Inhibitor in Preclinical Models of Diabetic Nephropathy at the 44th Annual Meeting of the American Society of Nephrology
2. Unigene Announces Positive Top-Line Results of Phase 2 Oral PTH Study for the Treatment of Osteoporosis in Postmenopausal Women
3. Boston Scientific Platinum Chromium ION™ Stent Demonstrates Positive Outcomes in PERSEUS Clinical Program
4. Regado Biosciences, Inc. Presents Positive Efficacy and Safety Substudy Data from the Phase 2b RADAR Trial for the REG1 Anticoagulation System at the Transcatheter Cardiovascular Therapeutics (TCT) Symposium 2011
5. NORTHWEST BIO Announces Positive Third Quarter Progress
6. Otonomy Presents Positive New Findings From Phase 1b Study of OTO-104 in Menieres Disease at International Conference
7. Elevation Pharmaceuticals Presents Positive Phase 2a Results in COPD Patients at the European Respiratory Society Annual Congress
8. Positive Phase 2 Trial Results from Neuroendocrine Tumor Cohort Presented at CIRSE
9. Ardea Biosciences Announces Positive End-of-Phase 2 Meetings with FDA for Lesinurad
10. Jennerex Reports Positive Mechanistic Proof-of-Concept Clinical Trial Results Using JX-594 to Treat Metastatic Melanoma
11. Intarcia Presents Positive Phase 2 48-week Results From ITCA 650 Study at the American Diabetes Association 71st Scientific Sessions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... 22, 2014 Involution Studios , ... of a new infographic, Understanding Ebola . ... beautifully designed, easy to follow informative tool for anyone ... outbreak, symptoms and prevention. , "As the news has ... 2014 Ebola outbreak represents not only a healthcare crisis ...
(Date:10/22/2014)... October 22, 2014 Grace Century, a ... healthcare projects, announces the addition of Dr. Yousef ... its advisory team. Dr. Siddiqui will provide further healthcare ... A graduate of University College Medical School ... in medicine in 2001. With further certification as a ...
(Date:10/22/2014)... 22, 2014   Synthetic Biologics, Inc. (NYSE ... for serious infections and diseases, announced today that the ... of Allowance for a composition of matter patent application ... program, SYN-004. This is Synthetic Biologics, first allowed ... and adds to the Company,s extensive C. difficile ...
(Date:10/22/2014)... Research and Markets  has announced the addition of ... Geography - Global Analysis and Forecast (2014 - 2020)" ... electronics, also called as polymer electronics or plastic electronics, ... small conductive molecules and electrically conductive polymers. It is ... carbon based, made using synthetic strategies developed in the ...
Breaking Biology Technology:Involution Studios' Ebola Infographic Provides Key Disease Information and Statistics at a Glance 2Dr. Yousef Siddiqui joins the Grace Century Advisory Team 2Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 2Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 3Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 4Global Organic Electronics (Semiconductor, Conductive, Dielectric and Substrate) Market - Analysis and Forecast (2014 - 2020) 2Global Organic Electronics (Semiconductor, Conductive, Dielectric and Substrate) Market - Analysis and Forecast (2014 - 2020) 3
... reveal critical evidence, as well as an identity, with ... University that detects trace amounts of explosives, drugs or ... new technology also can distinguish between overlapping fingerprints left ... optical forensic methods. , A team led by R. ...
... Brazil, Sept. 23 A bill designed to,strengthen ... by,the U.S. Senate Foreign Relations Committee, is a ... the United States to promote the production,and use ... the,Brazilian Sugarcane Industry Association (UNICA)., "It shows ...
... 23 Pressure,BioSciences, Inc. (Nasdaq: PBIO ... the Company,s pressure cycling technology ("PCT") was ... Fifth International Conference on,High Pressure Bioscience and ... San Diego, CA. The HPBB Conference was ...
Cached Biology Technology:Fingerprints provide clues to more than just identity 2New Bill to Expand Promotion of Biofuels Is a Welcome Boost for U.S.-Brazil Relations According to Brazilian Sugarcane Industry 2New Bill to Expand Promotion of Biofuels Is a Welcome Boost for U.S.-Brazil Relations According to Brazilian Sugarcane Industry 3Pressure Cycling Technology (PCT) Highlighted in Five Podium Presentations at the Fifth International Conference on High Pressure; PBI Introduces the Patent-pending 'PCT Shredder' at the Meeting 2Pressure Cycling Technology (PCT) Highlighted in Five Podium Presentations at the Fifth International Conference on High Pressure; PBI Introduces the Patent-pending 'PCT Shredder' at the Meeting 3Pressure Cycling Technology (PCT) Highlighted in Five Podium Presentations at the Fifth International Conference on High Pressure; PBI Introduces the Patent-pending 'PCT Shredder' at the Meeting 4
(Date:10/17/2014)... . To date, ... overdoses, doctors are often limited to supportive therapy such as ... combination of drugs involved. So what can be done if ... ETH professor Jean-Christophe Leroux from the Institute of Pharmaceutical Sciences ... question. "The task was to develop an agent that could ...
(Date:10/16/2014)... efficiently, they are anything but sustainable: environmental damage ... is becoming increasingly evident. Despite their disadvantages, however, ... regarded as the sole possibility of achieving higher ... Bernhard Schmid, an ecology professor at the University ... agriculture and forestry. After all, a new study ...
(Date:10/15/2014)... As our ability to assess the pandemic risk from ... developments, we must not allow ourselves to become complacent ... an international consortium of scientists. , Influenza pandemics arise ... have yet to develop widespread immunity – spreads in ... in the past 100 years, the worst of which ...
Breaking Biology News(10 mins):Emergency aid for overdoses 2Emergency aid for overdoses 3Plant communities produce greater yield than monocultures 2Plant communities produce greater yield than monocultures 3Scientists 'must not become complacent' when assessing pandemic threat from flu viruses 2
... REDWOOD CITY, Calif., Oct. 28 , WHAT: ... speak at the Dallas SecureWorld Expo in the Industry ... "Protecting the User-Led Aspect of Endpoint Security," Fulton will ... caused by end users. He will further examine how ...
... emerging for how important it is for pregnant women to ... day seem to have children who are less likely to ... from the Sahlgrenska Academy at the University of Gothenburg, ... Linkping University, which is conducting a population study called ABIS ...
... Olympus, a precision technology leader creating innovative opto-digital ... today announced the availability of VisiGlide 1 , its ... Terumo Corporation 2 to facilitate ERCP procedures ... of the bile and pancreatic ducts, the new 0.025 ...
Cached Biology News:DigitalPersona to Speak at Dallas SecureWorld Expo 2Vegetables can protect unborn child against diabetes 2Olympus introduces the VisiGlide, a single-use guidewire 2
Tan solid. A glycoside used to permeabilize cellular membranes. Exhibits hemolytic activity. Contaminants: ash: ≤10%. Soluble in H 2 O. pH 4.4 - 4.6. RTECS VQ1400000, CAS 8047-15-2. References:...
Anti Autotaxin /ENPP2 , - (Rabbit)...
... 2-Deoxy-2-(3-methyl-3-nitrosoureido)-D-glucopyranose Pale yellow solid. An N-nitroso-containing ... nitric oxide donor in pancreatic islets. ... Causes DNA alkylation and DNA strand ... ≥95% by HPLC. Soluble in H ...
Mouse monoclonal antibody to CDC2L5 - cell division cycle 2-like 5 (cholinesterase-related cell division controller)...
Biology Products: